U.S. health officials said on Thursday they were creating a better system for alerting securities regulators when they suspect a drug maker has made misleading statements about one of its products.
U.S. health officials said on Thursday they were creating a better system for alerting securities regulators when they suspect a drug maker has made misleading statements about one of its products.